Skip to main content
SpringerLink
Log in

Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma—not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

A Correction to this article was published on 28 November 2020

This article has been updated

Abstract

Peripheral T cell lymphomas (PTCL) are a heterogeneous group of non-Hodgkin lymphomas with poor outcomes. Adult T cell leukemia-lymphoma (ATL) and PTCL—not otherwise specified (PTCL-NOS)—are 2 common mature T cell lymphomas in Japan. Since it is unclear whether novel agents and treatment strategies incorporating hematopoietic cell transplantation have contributed to improved clinical outcomes in the real world, we performed a retrospective analysis using data from the population-based Osaka Cancer Registry. From 1977 to 2014, 1274 and 1143 patients were diagnosed with ATL or PTCL-NOS, respectively. Recently, the incidence of both diseases has gradually increased, and the age at diagnosis has risen. The 3-year overall survival (OS) rates in ATL patients were 12.0% in era 1 (1977–1999), 12.4% in era 2 (2000–2008), and 17.5% in era 3 (2009–2014) (P < 0.001). The 3-year OS rates in PTCL-NOS patients were 27.6% in era 1, 36.2% in era 2, and 35.0% in era 3 (P = 0.049). In conclusion, the incidences of ATL and PTCL-NOS have been increasing, particularly in elderly individuals. Clinical outcomes have improved in recent decades but are still unsatisfactory in both diseases. Thus, effective new treatment strategies incorporating novel agents are needed to further improve clinical outcomes in patients with ATL and PTCL-NOS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Change history

  • 28 November 2020

    A Correction to this paper has been published: <ExternalRef><RefSource>https://doi.org/10.1007/s00277-020-04308-8</RefSource><RefTarget Address="10.1007/s00277-020-04308-8" TargetType="DOI"/></ExternalRef>

References

  1. Vose J, Armitage J, Weisenburger D, International TCLP (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124–4130. https://doi.org/10.1200/JCO.2008.16.4558

    Article  PubMed  Google Scholar 

  2. Ishitsuka K, Tamura K (2014) Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol 15(11):e517–e526. https://doi.org/10.1016/S1470-2045(14)70202-5

    Article  CAS  PubMed  Google Scholar 

  3. Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, Tomotaka S, Morton LM, Weisenburger DD, Matsuo K (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164(4):536–545. https://doi.org/10.1111/bjh.12659

    Article  PubMed  Google Scholar 

  4. Chihara D, Ito H, Katanoda K, Shibata A, Matsuda T, Tajima K, Sobue T, Matsuo K (2012) Increase in incidence of adult T-cell leukemia/lymphoma in non-endemic areas of Japan and the United States. Cancer Sci 103(10):1857–1860. https://doi.org/10.1111/j.1349-7006.2012.02373.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Howlader N, Morton LM, Feuer EJ, Besson C, Engels EA (2016) Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends. Cancer Epidemiol Biomarkers Prev 25(1):174–179. https://doi.org/10.1158/1055-9965.Epi-15-0921

    Article  PubMed  Google Scholar 

  6. Morgensztern D, Walker GR, Koniaris LG, Lossos IS (2011) Lack of survival improvement in patients with peripheral T-cell lymphoma: a Surveillance, Epidemiology, and End Results analysis. Leuk Lymphoma 52(2):194–204. https://doi.org/10.3109/10428194.2010.542596

    Article  PubMed  Google Scholar 

  7. Crozier JA, Sher T, Yang D, Swaika A, Foran J, Ghosh R, Tun H, Colon-Otero G, Kelly K, Chanan-Khan A, Ailawadhi S (2015) Persistent disparities among patients with T-cell non-Hodgkin lymphomas and B-cell diffuse large cell lymphomas over 40 years: a SEER database review. Clin Lymphoma Myeloma Leuk 15(10):578–585. https://doi.org/10.1016/j.clml.2015.06.005

    Article  PubMed  PubMed Central  Google Scholar 

  8. Chihara D, Ito H, Izutsu K, Hattori M, Nishino Y, Ioka A, Matsuda T, Ito Y (2015) Advance and stagnation in the treatment of patients with lymphoma and myeloma: analysis using population-based cancer registry data in Japan from 1993 to 2006. Int J Cancer 137(5):1217–1223. https://doi.org/10.1002/ijc.29477

    Article  CAS  PubMed  Google Scholar 

  9. Katsuya H, Ishitsuka K (2017) Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma. J Clin Exp Hematop 57(3):87–97. https://doi.org/10.3960/jslrt.17008

    Article  PubMed  PubMed Central  Google Scholar 

  10. Schmitz N, de Leval L (2017) How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future. Br J Haematol 176(6):851–866. https://doi.org/10.1111/bjh.14473

    Article  CAS  PubMed  Google Scholar 

  11. Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, Horwitz S, Fields P, Tanase A, Bumbea H, Cwynarski K, Taylor G, Waldmann TA, Bittencourt A, Marcais A, Suarez F, Sibon D, Phillips A, Lunning M, Farid R, Imaizumi Y, Choi I, Ishida T, Ishitsuka K, Fukushima T, Uchimaru K, Takaori-Kondo A, Tokura Y, Utsunomiya A, Matsuoka M, Tsukasaki K, Watanabe T (2019) Revised adult T-cell leukemia-lymphoma International Consensus Meeting Report. J Clin Oncol 37(8):677–687. https://doi.org/10.1200/JCO.18.00501

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Phillips EH, Hodson A, Hermine O, Bazarbachi A, Cwynarski K (2016) Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplant? Bone Marrow Transplant 51(12):1549–1555. https://doi.org/10.1038/bmt.2016.154

    Article  CAS  PubMed  Google Scholar 

  13. Schmitz N, Lenz G, Stelljes M (2018) Allogeneic hematopoietic stem cell transplantation for T-cell lymphomas. Blood 132(3):245–253. https://doi.org/10.1182/blood-2018-01-791335

    Article  CAS  PubMed  Google Scholar 

  14. Kharfan-Dabaja MA, Kumar A, Ayala E, Hamadani M, Reimer P, Gisselbrecht C, d'Amore F, Jantunen E, Ishida T, Bazarbachi A, Foss F, Advani R, Fenske TS, Lazarus HM, Friedberg JW, Aljurf M, Sokol L, Tobinai K, Tse E, Burns LJ, Chavez JC, Reddy NM, Suzuki R, Ahmed S, Nademanee A, Mohty M, Gopal AK, Fanale MA, Pro B, Moskowitz AJ, Sureda A, Perales MA, Carpenter PA, Savani BN (2017) Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international collaborative effort on behalf of the guidelines committee of the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 23(11):1826–1838. https://doi.org/10.1016/j.bbmt.2017.07.027

    Article  PubMed  Google Scholar 

  15. Fuji S, Yamaguchi T, Inoue Y, Utsunomiya A, Moriuchi Y, Uchimaru K, Owatari S, Miyagi T, Taguchi J, Choi I, Otsuka E, Nakachi S, Yamamoto H, Kurosawa S, Tobinai K, Fukuda T (2017) Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation. Haematologica 102(7):1258–1265. https://doi.org/10.3324/haematol.2017.164996

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Fuji S, Kurosawa S, Inamoto Y, Murata T, Utsunomiya A, Uchimaru K, Yamasaki S, Inoue Y, Moriuchi Y, Choi I, Ogata M, Hidaka M, Yamaguchi T, Fukuda T (2018) Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis. Bone Marrow Transplant 53(7):905–908. https://doi.org/10.1038/s41409-017-0082-4

    Article  CAS  PubMed  Google Scholar 

  17. Bazarbachi A, Cwynarski K, Boumendil A, Finel H, Fields P, Raj K, Nagler A, Mohty M, Sureda A, Dreger P, Hermine O (2014) Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP. Bone Marrow Transplant 49(10):1266–1268. https://doi.org/10.1038/bmt.2014.143

    Article  CAS  PubMed  Google Scholar 

  18. Ishida T, Utsunomiya A, Jo T, Yamamoto K, Kato K, Yoshida S, Takemoto S, Suzushima H, Kobayashi Y, Imaizumi Y, Yoshimura K, Kawamura K, Takahashi T, Tobinai K, Ueda R (2017) Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies. Cancer Sci 108(10):2022–2029. https://doi.org/10.1111/cas.13343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ishida T, Jo T, Takemoto S, Suzushima H, Suehiro Y, Choi I, Yoshimitsu M, Saburi Y, Nosaka K, Utsunomiya A, Kobayashi Y, Yamamoto K, Fujiwara H, Ishitsuka K, Yoshida S, Taira N, Imada K, Kato K, Moriuchi Y, Yoshimura K, Takahashi T, Tobinai K, Ueda R (2019) Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation. Br J Haematol 184(3):479–483. https://doi.org/10.1111/bjh.15123

    Article  PubMed  Google Scholar 

  20. Phillips AA, Fields PA, Hermine O, Ramos JC, Beltran BE, Pereira J, Wandroo F, Feldman T, Taylor GP, Sawas A, Humphrey J, Kurman M, Moriya J, Dwyer K, Leoni M, Conlon K, Cook L, Gonsky J, Horwitz SM, Study G (2019) Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma. Haematologica 104(5):993–1003. https://doi.org/10.3324/haematol.2018.205096

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Morishima T, Matsumoto Y, Koeda N, Shimada H, Maruhama T, Matsuki D, Nakata K, Ito Y, Tabuchi T, Miyashiro I (2019) Impact of comorbidities on survival in gastric, colorectal, and lung cancer patients. J Epidemiol 29(3):110–115. https://doi.org/10.2188/jea.JE20170241

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kanda Y (2013) Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 48(3):452–458. https://doi.org/10.1038/bmt.2012.244

    Article  CAS  PubMed  Google Scholar 

  23. Willems L, Hasegawa H, Accolla R, Bangham C, Bazarbachi A, Bertazzoni U, Carneiro-Proietti AB, Cheng H, Chieco-Bianchi L, Ciminale V, Coelho-Dos-Reis J, Esparza J, Gallo RC, Gessain A, Gotuzzo E, Hall W, Harford J, Hermine O, Jacobson S, Macchi B, Macpherson C, Mahieux R, Matsuoka M, Murphy E, Peloponese JM, Simon V, Tagaya Y, Taylor GP, Watanabe T, Yamano Y (2017) Reducing the global burden of HTLV-1 infection: An agenda for research and action. Antiviral Res 137:41–48. https://doi.org/10.1016/j.antiviral.2016.10.015

    Article  CAS  PubMed  Google Scholar 

  24. Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y, Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K, Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T (2010) Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 116(8):1369–1376. https://doi.org/10.1182/blood-2009-10-247510

    Article  CAS  PubMed  Google Scholar 

  25. Chihara D, Ito H, Matsuda T, Katanoda K, Shibata A, Taniguchi S, Utsunomiya A, Sobue T, Matsuo K (2013) Association between decreasing trend in the mortality of adult T-cell leukemia/lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT). Blood Cancer J 3:e159. https://doi.org/10.1038/bcj.2013.57

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Choi I, Tanosaki R, Uike N, Utsunomiya A, Tomonaga M, Harada M, Yamanaka T, Kannagi M, Okamura J, Group Aa-HS (2011) Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials. Bone Marrow Transplant 46(1):116–118. https://doi.org/10.1038/bmt.2010.92

    Article  CAS  PubMed  Google Scholar 

  27. Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T, Takemoto S, Suzushima H, Tsukasaki K, Nosaka K, Fujiwara H, Ishitsuka K, Inagaki H, Ogura M, Akinaga S, Tomonaga M, Tobinai K, Ueda R (2012) Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 30(8):837–842. https://doi.org/10.1200/JCO.2011.37.3472

    Article  CAS  PubMed  Google Scholar 

  28. Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K, Yamaguchi K, Yamada Y, Hanada S, Tamura K, Nakamura S, Inagaki H, Ohshima K, Kiyoi H, Ishida T, Matsushima K, Akinaga S, Ogura M, Tomonaga M, Ueda R (2010) Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 28(9):1591–1598. https://doi.org/10.1200/JCO.2009.25.3575

    Article  CAS  PubMed  Google Scholar 

  29. Ishida T, Fujiwara H, Nosaka K, Taira N, Abe Y, Imaizumi Y, Moriuchi Y, Jo T, Ishizawa K, Tobinai K, Tsukasaki K, Ito S, Yoshimitsu M, Otsuka M, Ogura M, Midorikawa S, Ruiz W, Ohtsu T (2016) Multicenter phase ii study of lenalidomide in relapsed or recurrent adult T-cell leukemia/lymphoma: ATLL-002. J Clin Oncol 34(34):4086–4093. https://doi.org/10.1200/JCO.2016.67.7732

    Article  CAS  PubMed  Google Scholar 

  30. Wilcox RA (2018) Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOP. Lancet Haematol 5(5):e182–e183. https://doi.org/10.1016/S2352-3026(18)30047-4

    Article  PubMed  Google Scholar 

  31. Osaka Prefectural Department of Public Health and Welfare, Osaka Medical Association, Osaka International Center Institute: Annual Report of Osaka Cancer Registry No.82 - cancer incidence and medical care in Osaka in 2015 2014 and the survival in 2010 - . (2019). OPDPHW

  32. Kinoshita FL, Ito Y, Nakayama T (2016) Trends in Lung Cancer Incidence Rates by Histological Type in 1975-2008: A Population-Based Study in Osaka, Japan. J Epidemiol 26(11):579–586. https://doi.org/10.2188/jea.JE20150257

    Article  PubMed  Google Scholar 

  33. Okawa S, Tabuchi T, Morishima T, Koyama S, Taniyama Y, Miyashiro I (2020) Hospital volume and postoperative 5-year survival for five different cancer sites: a population-based study in Japan. Cancer Sci 111(3):985–993. https://doi.org/10.1111/cas.14309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Laurent C, Baron M, Amara N, Haioun C, Dandoit M, Maynadie M, Parrens M, Vergier B, Copie-Bergman C, Fabiani B, Traverse-Glehen A, Brousse N, Copin MC, Tas P, Petrella T, Rousselet MC, Briere J, Charlotte F, Chassagne-Clement C, Rousset T, Xerri L, Moreau A, Martin A, Damotte D, Dartigues P, Soubeyran I, Peoch M, Dechelotte P, Michiels JF, de Mascarel A, Berger F, Bossard C, Arbion F, Quintin-Roue I, Picquenot JM, Patey M, Fabre B, Sevestre H, Le Naoures C, Chenard-Neu MP, Bastien C, Thiebault S, Martin L, Delage M, Filleron T, Salles G, Molina TJ, Delsol G, Brousset P, Gaulard P (2017) Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French lymphopath network. J Clin Oncol 35(18):2008–2017. https://doi.org/10.1200/JCO.2016.71.2083

    Article  PubMed  Google Scholar 

  35. Bellei M, Sabattini E, Pesce EA, Ko YH, Kim WS, Cabrera ME, Martinez V, Dlouhy I, Paes RP, Barrese T, Vassallo J, Tarantino V, Vose J, Weisenburger D, Rudiger T, Federico M, Pileri S (2017) Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study. Hematol Oncol 35(4):630–636. https://doi.org/10.1002/hon.2316

    Article  PubMed  Google Scholar 

Download references

Funding

This research was partially supported by the Practical Research for Innovative Cancer Control program of the Japan Agency for Medical Research and Development (17ck0106342h0001), a National Cancer Research and Development Fund (29-A-14), and Health, Labor, and Welfare Sciences Research Grants [H30-Gantaisaku-ippan-009].

Author information

Authors and Affiliations

  1. Department of Hematology, Osaka International Cancer Institute, Osaka, Japan

    Shigeo Fuji, Shuhei Kida & Jun Ishikawa

  2. Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan

    Kayo Nakata, Toshitaka Morishima & Isao Miyashiro

Authors
  1. Shigeo Fuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuhei Kida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kayo Nakata
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshitaka Morishima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Isao Miyashiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jun Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S.F., S.K., K.N., and T.M. designed the research. S.F. and K. N analyzed the data. and S.F., S.K., K.N., T.M., I.M., and J. I wrote the paper. All the authors agreed to submit this article.

Corresponding author

Correspondence to Shigeo Fuji.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study was approved by the institutional review board of the Osaka International Cancer Institute in Osaka, Japan (No. 19088).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original version of this article was revised: This article was originally published without the figures 1C and 1D, thus, it requested to be revised.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fuji, S., Kida, S., Nakata, K. et al. Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma—not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry. Ann Hematol 100, 157–165 (2021). https://doi.org/10.1007/s00277-020-04308-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-020-04308-8

Keywords

Search

Navigation